200,000+ products from a single source!
sales@angenechem.com
147116-67-4 | 1-Azabicyclo[2.2.2]octan-3-amine, N-[[5-(1,1-dimethylethyl)-2-methoxyphenyl]methyl]-2-(diphenylmethyl)-, (2S,3S)-
CAS No: 147116-67-4 Catalog No: AG001ELW MDL No:
Product Description
Catalog Number:
AG001ELW
Chemical Name:
1-Azabicyclo[2.2.2]octan-3-amine, N-[[5-(1,1-dimethylethyl)-2-methoxyphenyl]methyl]-2-(diphenylmethyl)-, (2S,3S)-
CAS Number:
147116-67-4
Molecular Formula:
C32H40N2O
Molecular Weight:
468.6728
IUPAC Name:
(2S,3S)-2-benzhydryl-N-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine
InChI:
InChI=1S/C32H40N2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3/t30-,31-/m0/s1
InChI Key:
OMPCVMLFFSQFIX-CONSDPRKSA-N
SMILES:
COc1ccc(cc1CN[C@H]1C2CCN([C@H]1C(c1ccccc1)c1ccccc1)CC2)C(C)(C)C
UNII:
4XE2T9H4DH
Properties
Complexity:
620
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
2
Defined Bond Stereocenter Count:
0
Exact Mass:
468.314g/mol
Formal Charge:
0
Heavy Atom Count:
35
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
468.685g/mol
Monoisotopic Mass:
468.314g/mol
Rotatable Bond Count:
8
Topological Polar Surface Area:
24.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7
Literature
| Title | Journal |
|---|---|
| Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs. | Veterinary anaesthesia and analgesia 20120301 |
| In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis. | Archives of toxicology 20111201 |
| Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs. | American journal of veterinary research 20111201 |
| The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog. | Veterinary anaesthesia and analgesia 20110901 |
| Phase I evaluation of STA-1474, a prodrug of the novel HSP90 inhibitor ganetespib, in dogs with spontaneous cancer. | PloS one 20110101 |
| Acute vomiting in cats: rational treatment selection. | Journal of feline medicine and surgery 20100301 |
| Acute pancreatitis attributed to dietary indiscretion in a female mixed breed canine. | The Canadian veterinary journal = La revue veterinaire canadienne 20100201 |
| Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs. | Journal of veterinary internal medicine 20100101 |
| Effect of refrigeration of the antiemetic Cerenia (maropitant) on pain on injection. | Veterinary therapeutics : research in applied veterinary medicine 20090101 |
| Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs. | Journal of veterinary pharmacology and therapeutics 20081201 |
| Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs. | Journal of veterinary pharmacology and therapeutics 20081201 |
| Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs. | Journal of veterinary pharmacology and therapeutics 20081201 |
| Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats. | Journal of veterinary pharmacology and therapeutics 20080601 |
| Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs. | The Veterinary record 20070929 |
| The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model. | Journal of veterinary pharmacology and therapeutics 20070801 |
| The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs. | Journal of veterinary pharmacology and therapeutics 20070801 |
| [New antiemetics: maropitant citrate]. | Tijdschrift voor diergeneeskunde 20070515 |
| Efficacy of injectable maropitant (Cerenia) in a randomized clinical trial for prevention and treatment of cisplatin-induced emesis in dogs presented as veterinary patients. | Veterinary and comparative oncology 20070301 |
| The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe. | The Journal of small animal practice 20070201 |
| Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs. | American journal of veterinary research 20070101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.